UPS has completed the acquisition of Andlauer Healthcare Group, a provider of logistics and refrigerated transportation services for the healthcare sector in Canada, for $1.6 billion in cash, the company announced Monday. Andlauer’s customers include companies that make pharmaceuticals, vaccines, biologics, blood products, nutraceuticals, medical devices, consumer healthcare, animal health, and health and beauty products. Michael Andlauer, founder and CEO of AHG, will lead UPS Canada Healthcare and AHG, UPS said. Publicly traded Andlauer will be delisted from the Toronto Stock Exchange. “The addition of Andlauer’s capabilities will further strengthen our solutions in global health care logistics, particularly in North America,” UPS CEO Carol Tomé said on the company’s earnings call last Tuesday. UPS (NYSE: UPS) is focusing resources on the healthcare sector, where value-added services and customized solutions for highly sensitive products allow the company to charge premium rates, unlike the core domestic parcel business where yields are often low and volumes are softening. Global third-party logistics providers, including FedEx and DHL, are also aggressively expanding their healthcare logistics portfolios. UPS last year said it plans to double revenue in health care logistics to $20 billion through organic growth and acquisitions by 2026. With the addition of Andlauer’s’s specialized cold chain network and expertise, UPS Healthcare customers will benefit from reduced transit times, enhanced end-to-end visibility, and deeper global reach, UPS said. Nearly 60% of Andlauer’s revenue comes from temperature-controlled ground transportation, where it uses a blend of owner-operated and employee drivers for courier and less-than-truckload service under brands such as ATS Healthcare, Boyle Transportation and Skelton Truck Lines. Partner companies in warehousing and distribution include Accuristix and Logistics Support Unit, according to Andlauer’s website. The Canadian company also provides specialized packaging services and airfreight forwarding. In September, UPS had to abandon its planned purchase of Mexican courier Estafeta after the sides couldn’t meet closing conditions. Click here for more FreightWaves stories by Eric Kulisch. Sign up for the biweekly The Delivery newsletter here. RECOMMENDED READING: UPS inks $1.6 billion deal for Canadian healthcare logistics provider UPS, Postal Service to reunite for delivery of low-budget shipments The post UPS expands healthcare reach with completion of Andlauer deal appeared first on FreightWaves. View Comments
UPS expands healthcare reach with completion of Andlauer deal
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...